Crossmark

Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(<scp>iv</scp>) prodrugs with high anti-tumor activity

Crossref DOI link: https://doi.org/10.1039/C9DT04594E

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Tan, Ming-Xiong https://orcid.org/0000-0002-5352-4030
Wang, Zhen-Feng

Qin, Qi-Pin https://orcid.org/0000-0001-9596-4512
Zou, Bi-Qun https://orcid.org/0000-0001-5339-0258
Liang, Hong
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (21761033)

National Natural Science Foundation of China (21867017)

Natural Science Foundation of Guangxi Province Province (2018GXNSFBA138021)

Natural Science Foundation of Guangxi Province Province (2018GXNSFBA281188)

Natural Science Foundation of Guangxi Province Province (2016GXNSFAA380300)
License Information

Accepted Manuscript valid from 2021-01-08
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Ming-Xiong Tan (ORCID)

: Qi-Pin Qin (ORCID)

: Bi-Qun Zou (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 30 November 2019; Accepted 7 January 2020; Accepted Manuscript published 8 January 2020; Advance Article published 16 January 2020; Version of Record published 5 February 2020